Management tracks: Glympse, Kaleido, Lundbeck

Non-invasive sensor company Glympse Bio Inc. (Cambridge, Mass.) hired Caroline Loew as the company's first president and CEO. Loew was VP and head of R&D strategy and planning at Bristol-Myers Squibb Co. (NYSE:BMY). Glympse also appointed serial entrepreneur Robert Langer to its board.

Microbiome company Kaleido Biosciences Inc. (Bedford, Mass.) hired Katharine Knobil as CMO and head of R&D. She was CMO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). ...